Jazz Pharmaceuticals reported $3.5M in Interest Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Cara Therapeutics CARA:US USD 665K 399K
Eli Lilly LLY:US USD 20.1M 9.9M
Endo International ENDP:US USD 178K 31K
Merck & Co MRK:US USD 40M 25M
Nektar Therapeutics NKTR:US USD 2.05M 954K
Pacira PCRX:US USD 1.23M 982K
Pfizer PFE:US USD 70M 40M
Phibro Animal Health PAHC:US USD 628K 324K
Revance Therapeutics RVNC:US USD 1.16M 546K
Supernus Pharmaceuticals SUPN:US USD 2.8M 1.01M